XML 33 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2023
Dec. 31, 2022
Jun. 30, 2021
Cash flows from operating activities:        
Net income and comprehensive income $ 138,828 $ 240,132 $ 239,942 $ 302,776
Adjustments to reconcile net income and comprehensive income to net cash provided by operating activities:        
Depreciation, depletion and amortization 99,685 164,937 178,935 183,569
Gain on sale of Peak Gold JV interest       (33,906)
Non-cash employee stock compensation expense 3,218 9,696 8,411 5,730
Fair value changes in equity securities 1,350 147 1,503 (6,017)
Deferred tax (benefit) expense 2,510 (6,469) (19,836) 456
Impairment of royalty interests   0 4,287  
Other 1,090 779 979 971
Changes in assets and liabilities:        
Royalty receivables (6,846) 521 4,683 (19,552)
Stream inventory 6,077 2,868 (1,049) (6,014)
Income tax receivable (396) 390 1,849 (2,085)
Prepaid expenses and other assets (1,374) (4,369) (3,908) 318
Accounts payable 76 4,756 211 3,237
Income tax payable 4,591 (508) (3,005) 1,156
Uncertain tax positions (910)     (24,518)
Other liabilities 884 2,912 4,343 1,030
Net cash provided by operating activities 248,783 415,792 417,345 407,151
Cash flows from investing activities:        
Acquisition of stream and royalty interests (281,066) (2,678) (922,155) (168,147)
Khoemacau subordinated debt facility (7,000)     (18,000)
Proceeds from sale of Peak Gold JV interest       49,154
Proceeds from sale of Contango shares       12,146
Proceeds from sale of equity securities       8,651
Other (64) (151) (721) (541)
Net cash used in investing activities (288,130) (2,829) (922,876) (116,737)
Cash flows from financing activities:        
Repayment of debt (100,000) (325,000) (125,000) (305,000)
Borrowings from revolving credit facility 100,000   700,000  
Net payments from issuance of common stock (921) (1,383) (1,447) (1,465)
Common stock dividends (39,374) (98,567) (91,925) (76,099)
Other (2,723) (2,432) (1,062) (1,062)
Net cash (used in) provided by financing activities (43,018) (427,382) 480,566 (383,626)
Net decrease in cash and equivalents (82,365) (14,419) (24,965) (93,212)
Cash and equivalents at beginning of period 225,916 118,586 143,551 319,128
Cash and equivalents at end of period $ 143,551 $ 104,167 $ 118,586 $ 225,916